NCPA Media: Health Care

  • Jun 21, 2016

    Cutting Competition Won’t Solve the Problem of Rising Drug Prices

    Overregulating Drug Plans Could Raise Costs to Consumers: NCPA

    Dallas, TX

    Would requiring disclosure of wholesale prices lower prescription drug costs? Experts say no, according to a new report by National Center for Policy Analysis Senior Fellow Devon Herrick.

    In a misguided attempt to combat the high prices of some new and specialty drugs, a few politicians and trade lobbyists for pharmacies and drug makers have begun to blame high drug prices on the administrators of employee drug plans – suggesting drug plans are not passing on their discounts to consumers and employers.

    This “bogus argument” posits that drug prices would be lower if drug plans were required to disclose the wholesale prices – a requirement that would be detrimental to any wholesale industry.

    Regardless of the industry, wholesale prices are often negotiated among private parties and are generally considered proprietary. “If competing hardware stores knew the exact wholesale prices Home Depot negotiated with suppliers, all competing stores would bargain aggressively for the same price. Over time, the likely result is that manufacturers would ultimately set one uniform wholesale price higher than the price volume purchasers would otherwise obtain,” says Herrick.

    The end result? Highly competitive firms would no longer be able to leverage buying power and pass on discounted prices to consumers.

    “Drugs are affordable for most consumers because of competition among Pharmacy Benefit Managers (PBMs),” adds Herrick. “Taking away PBMs’ ability to compete by regulating price transparency would harm consumers in the long run."

    A Bogus Solution for High Drug Costs:

  • May 31, 2016

    How to Pay for Medicare

    Four reforms could rein in Medicare spending growth: NCPA

    NCPA: Rising numbers of retirees and excess cost growth have made it imperative that we chance how the Medicare is financed – or the cost burden will crush taxpayers, according to a new study by NCPA Senior Fellows Andrew J. Rettenmaier and Thomas R. Saving.

  • May 30, 2016

    Pharmacists group pushing for expanded ‘preferred’ Medicare networks

    Arizona Business Daily: Preferred networks are at the root of how benefits managers have lowered drug costs for Medicare recipients, says NCPA Senior Fellow Devon Herrick in this article from Arizona Business Daily.

  • May 24, 2016

    As national pharmacy group lobbies for Lipinski-backed bill, critics say measure would raise drug prices

    West Cook News: NCPA Senior Fellow Devon Herrick is cited in this article from West Cook News on why recent legislation would “weaken the tools insurers and PBMs use to negotiate low drug prices with pharmacies on consumers’ behalf.”

  • May 24, 2016

    Critics claim Deutch-backed Medicare pharmacy bill would lead to higher drug prices for seniors

    Florida Business Daily: NCPA Senior Fellow Devon Herrick is cited on efforts from pharmacies to affect legislation in order to allow them to charge more in this article from Florida Business Daily.

  • May 19, 2016

    Americans Giving Up Smoking Can Cut The Country's Healthcare Spending By $63 Billion

    Parent Herald: Research from the NCPA explaining why health care spending is not a burden on the U.S. economy is cited in this article from the Parent Herald.

  • May 18, 2016

    Data Insights from the 2016 ACA Marketplace

    California Broker Magazine: NCPA Senior Fellow Devon Herrick outlines a plan to replace the Affordable Care Act in this article from California Broker Magazine.

  • May 18, 2016

    Not so easy to cash in on your ObamaCare plan

    One News Now: Difficulty locating a doctor or hospital that accepts your Obamacare plan is a widespread problem, says NCPA Senior Fellow Devon Herrick in an article from One News Now.

porno izle